NAFDAC:Counterfeit drugs market booms amid staff shortage, poor funding

With the recent spike in the cost of pharmaceutical products nationwide, the menace of fake and substandard drugs has also hit a new record – raising fresh posers on the regulatory duties of the National Agency for Food, Drug Administration and Control (NAFDAC)